Target Name: DHRS7B
NCBI ID: G25979
Other Name(s): CGI-93 | Short chain dehydrogenase/reductase family 32C, member 1 | short-chain dehydrogenase/reductase family 32C member 1 | Dehydrogenase/reductase (SDR family) member 7B | Dehydrogenase/reductase SDR family member 7B | Short-chain dehydrogenase/reductase family 32C member 1 | dehydrogenase/reductase 7B | Dehydrogenase/reductase SDR family member 7B (isoform 1) | DHRS7B variant 1 | dehydrogenase/reductase (SDR family) member 7B | SDR32C1 | Protein SDR32C1 | DRS7B_HUMAN | Dehydrogenase/reductase 7B, transcript variant 1

DHRS7B: A Potential Drug Target for Various Diseases

DHRS7B (CGI-93) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is doublecortin-like hormone receptor subfamily 7 member B, and it is a member of the superfamily of cytoskeletal proteins known as the calbindin gene family.

DHRS7B is a protein that is characterized by its ability to interact with calcitonin, a hormone that is produced by the parafollicular cells (mung bean) of the thyroid gland. Calcitonin is known for its ability to regulate various physiological processes in the body, including metabolism, growth, and development.

One of the key functions of DHRS7B is its role in the regulation of calcitonin signaling. DHRS7B is known to interact with the calcitonin receptor, which is a protein that is expressed in various tissues of the body, including the brain. The interaction between DHRS7B and the calcitonin receptor allows for the regulation of various physiological processes that are dependent on calcitonin.

In addition to its role in the regulation of calcitonin signaling, DHRS7B is also known to be involved in the regulation of inflammation and cellular signaling. It is has been shown to play a role in the regulation of various signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway.

DHRS7B is also of interest as a potential drug target. Its interaction with calcitonin and its role in the regulation of various physiological processes make it a potential target for the development of new treatments for various diseases. Additionally, its involvement in the regulation of inflammation and cellular signaling also makes it a potential target for the development of new treatments for autoimmune diseases.

In conclusion, DHRS7B is a protein that is characterized by its ability to interact with calcitonin and its role in the regulation of various physiological processes in the body. Its potential as a drug target makes it an attractive target for the development of new treatments for various diseases. Further research is needed to fully understand its role in the regulation of calcitonin signaling and its potential as a drug target.

Protein Name: Dehydrogenase/reductase 7B

Functions: Putative oxidoreductase

More Common Targets

DHRS7C | DHRS9 | DHRSX | DHTKD1 | DHX15 | DHX16 | DHX29 | DHX30 | DHX32 | DHX33 | DHX34 | DHX35 | DHX36 | DHX37 | DHX38 | DHX40 | DHX57 | DHX58 | DHX8 | DHX9 | DIABLO | Diacylglycerol Acyltransferase (DGAT) | Diacylglycerol kinase | DIAPH1 | DIAPH2 | DIAPH3 | DIAPH3-AS1 | DICER1 | DICER1-AS1 | Dickkopf protein | DIDO1 | DiGeorge syndrome critical region gene 9 | Dimethylaniline monooxygenase [N-oxide-forming] | DIMT1 | DINOL | DIO1 | DIO2 | DIO2-AS1 | DIO3 | DIO3OS | DIP2A | DIP2A-IT1 | DIP2B | DIP2C | DIP2C-AS1 | Dipeptidase | Dipeptidyl-Peptidase | DIPK1A | DIPK1B | DIPK1C | DIPK2A | DIPK2B | DIRAS1 | DIRAS2 | DIRAS3 | DIRC1 | DIRC3 | DIRC3-AS1 | DIS3 | DIS3L | DIS3L2 | DISC1 | DISC1FP1 | DISC2 | Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype) | DISP1 | DISP2 | DISP3 | DIXDC1 | DKC1 | DKFZp434L192 | DKFZp451A211 | DKFZp451B082 | DKFZP586I1420 | DKK1 | DKK2 | DKK3 | DKK4 | DKKL1 | DLAT | DLC1 | DLD | DLEC1 | DLEU1 | DLEU2 | DLEU2L | DLEU7 | DLEU7-AS1 | DLG1 | DLG1-AS1 | DLG2 | DLG3 | DLG3-AS1 | DLG4 | DLG5 | DLG5-AS1 | DLGAP1 | DLGAP1-AS1 | DLGAP1-AS2 | DLGAP1-AS5